• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CB1受体拮抗剂利莫那班逆转喂食糖果饮食的雌性Wistar大鼠的内脏脂肪过多情况。

Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant.

作者信息

Herling A W, Kilp S, Juretschke H-P, Neumann-Haefelin C, Gerl M, Kramer W

机构信息

Therapeutic Department Metabolism, Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.

出版信息

Int J Obes (Lond). 2008 Sep;32(9):1363-72. doi: 10.1038/ijo.2008.105. Epub 2008 Jul 15.

DOI:10.1038/ijo.2008.105
PMID:18626484
Abstract

OBJECTIVE

The severity of obesity is often more determined by the distribution of fat depots rather than by body weight itself. Therefore, the effect of rimonabant on fat distribution pattern was investigated in female candy-fed Wistar rats.

DESIGN

Female Wistar rats were fed a high fat, high carbohydrate (candy-) diet for 12 weeks. During the last 6 weeks rats were treated with rimonabant. Food intake and body weight development were investigated, as well as effects on total body fat, especially visceral fat and ectopic lipid accumulation in skeletal muscle and liver, determined by in vivo magnetic resonance imaging/magnetic resonance spectroscopy.

RESULTS

Candy-diet increased body weight, which was predominantly due to the increased total fat mass with predominance of visceral fat accumulation. Treatment with rimonabant fully reversed the weight gain and fat deposition in the visceral cavity and skeletal muscle, in contrast to pair feeding. In spite of an only transient reduction of food intake, body weight reduction, as well as normalized body fat, reduced visceral fat and intramyocellular lipids were maintained over the treatment period.

CONCLUSIONS

We conclude that additional factors other than reduced caloric intake must be responsible for the improvements in these lipid parameters. The complete cluster of results is consistent with increased lipid oxidation caused by rimonabant.

摘要

目的

肥胖的严重程度通常更多地取决于脂肪储存部位的分布,而非体重本身。因此,在喂食糖果的雌性Wistar大鼠中研究了利莫那班对脂肪分布模式的影响。

设计

将雌性Wistar大鼠喂食高脂肪、高碳水化合物(糖果)饮食12周。在最后6周,大鼠接受利莫那班治疗。研究了食物摄入量和体重变化,以及通过体内磁共振成像/磁共振波谱法测定的对全身脂肪,尤其是内脏脂肪以及骨骼肌和肝脏中异位脂质蓄积的影响。

结果

糖果饮食增加了体重,这主要归因于总脂肪量增加,以内脏脂肪蓄积为主。与配对喂食相比,利莫那班治疗完全逆转了体重增加以及内脏腔和骨骼肌中的脂肪沉积。尽管食物摄入量仅短暂减少,但在治疗期间体重减轻以及身体脂肪正常化、内脏脂肪减少和肌细胞内脂质减少得以维持。

结论

我们得出结论,除热量摄入减少外,其他因素必定是这些脂质参数改善的原因。完整的结果集与利莫那班引起的脂质氧化增加一致。

相似文献

1
Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant.CB1受体拮抗剂利莫那班逆转喂食糖果饮食的雌性Wistar大鼠的内脏脂肪过多情况。
Int J Obes (Lond). 2008 Sep;32(9):1363-72. doi: 10.1038/ijo.2008.105. Epub 2008 Jul 15.
2
Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.在喂食糖果的Wistar大鼠中,与减少食物摄入量相比,增加能量消耗对利莫那班减轻体重的作用贡献更大。
Endocrinology. 2008 May;149(5):2557-66. doi: 10.1210/en.2007-1515. Epub 2008 Feb 14.
3
Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs.利莫那班可防止犬在高脂喂养期间内脏脂肪和皮下脂肪的进一步堆积。
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1311-8. doi: 10.1152/ajpendo.90972.2008. Epub 2009 Apr 14.
4
Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.CB1拮抗剂对葡萄糖和脂质代谢的食物摄入量无关效应。
Obesity (Silver Spring). 2009 Aug;17(8):1641-5. doi: 10.1038/oby.2009.84. Epub 2009 Mar 26.
5
The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.大麻素CB1受体反向激动剂利莫那班,因食物摄入量减少,可改变饮食诱导肥胖大鼠的体重和脂联素功能。
Pharmacol Biochem Behav. 2006 Jun;84(2):353-9. doi: 10.1016/j.pbb.2006.06.001. Epub 2006 Jun 30.
6
Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.大麻素系统在肌肉中的表达:高脂肪饮食和 CB1 受体阻断的影响。
Biochem J. 2011 Jan 1;433(1):175-85. doi: 10.1042/BJ20100751.
7
Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.大麻素受体1拮抗剂治疗对瘦大鼠食物摄入量和血脂的影响。
Obesity (Silver Spring). 2008 Nov;16(11):2451-5. doi: 10.1038/oby.2008.390. Epub 2008 Aug 14.
8
Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.大麻素和神经肽 Y 系统对肥胖和脂质氧化的相加作用。
Diabetes Obes Metab. 2010 Jul;12(7):591-603. doi: 10.1111/j.1463-1326.2009.01193.x.
9
Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.利莫那班对高甘油三酯/低高密度脂蛋白胆固醇血脂异常、腹内脂肪堆积及肝脏脂肪的影响:ADAGIO-脂质试验
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):416-23. doi: 10.1161/ATVBAHA.108.176362. Epub 2008 Dec 26.
10
Addition of a low dose of rimonabant to orlistat therapy decreases weight gain and reduces adiposity in dietary obese rats.添加低剂量利莫那班到奥利司他治疗中可以减少饮食诱导肥胖大鼠的体重增加和脂肪堆积。
Clin Exp Pharmacol Physiol. 2012 Jun;39(6):551-9. doi: 10.1111/j.1440-1681.2012.05717.x.

引用本文的文献

1
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.靶向内源性大麻素 CB1 受体治疗体重紊乱:过去和现在 CB1 药物治疗潜力的临床前和临床综述。
Biomolecules. 2020 Jun 4;10(6):855. doi: 10.3390/biom10060855.
2
CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A).CB1 受体依赖和独立的内脂素在原代大鼠脂肪细胞中的诱导作用通过反向激动剂利莫那班(SR141716A)。
Molecules. 2020 Feb 18;25(4):896. doi: 10.3390/molecules25040896.
3
Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues.
脑及外周组织中能量平衡调节的多种内源性大麻素介导机制。
Cell Mol Life Sci. 2019 Apr;76(7):1341-1363. doi: 10.1007/s00018-018-2994-6. Epub 2019 Jan 1.
4
Effect of different intensities of physical activity on cardiometabolic markers and vascular and cardiac function in adult rats fed with a high-fat high-carbohydrate diet.不同强度的体育活动对高脂高碳水化合物饮食成年大鼠心脏代谢标志物以及血管和心脏功能的影响。
J Sport Health Sci. 2018 Jan;7(1):109-119. doi: 10.1016/j.jshs.2016.08.001. Epub 2016 Aug 3.
5
Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages.脂肪细胞大麻素受体CB1调节能量平衡和交替活化巨噬细胞。
J Clin Invest. 2017 Nov 1;127(11):4148-4162. doi: 10.1172/JCI83626. Epub 2017 Oct 16.
6
Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.重新审视内源性大麻素系统及其在肥胖症和相关疾病中的治疗潜力。
Curr Diab Rep. 2017 Sep 14;17(10):99. doi: 10.1007/s11892-017-0924-x.
7
2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism.内源性大麻素 2-花生四烯酰甘油信号在大脑前脑调节全身能量代谢。
Cell Metab. 2012 Mar 7;15(3):299-310. doi: 10.1016/j.cmet.2012.01.021.
8
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.急性大麻素受体 1 型 (CB1R) 调节通过中枢神经系统外的作用影响小鼠的胰岛素敏感性。
Diabetologia. 2011 May;54(5):1181-9. doi: 10.1007/s00125-011-2082-z. Epub 2011 Feb 22.
9
Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity.大麻素受体 1 拮抗剂利莫那班对饮食诱导肥胖小鼠炎症的影响。
Obesity (Silver Spring). 2011 Mar;19(3):505-13. doi: 10.1038/oby.2010.213. Epub 2010 Sep 30.
10
Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs.利莫那班可防止犬在高脂喂养期间内脏脂肪和皮下脂肪的进一步堆积。
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1311-8. doi: 10.1152/ajpendo.90972.2008. Epub 2009 Apr 14.